The next step in immorality: charging to create and cure disease
Surrogate markers are seductive. In clinical trials and regulatory decisions, why not reach for something quick, convenient, and relatively cheap? Why stop patients receiving a treatment of plausible…
Read Original Article: The next step in immorality: charging to create and cure disease »
